Assessment of biophysical properties of the first-in-class anti-cancer IgE antibody drug MOv18 IgE demonstrates monomeric purity and stabilityPaul Considine(University of Strathclyde), Zahra Rattray(University of Strathclyde)mAbsMay 28, 202510.1080/19420862.2025.2512211Cited by 3SaveCiteExport RISWatch citationsRelated PapersENT2 facilitates brain endothelial cell penetration and blood-brain barrier transport by a tumor-targeting anti-DNA autoantibody|JCI Insight|2021|20The Differential Metabolic Signature of Breast Cancer Cellular Response to Olaparib Treatment|Cancers|2022|14Nanoparticle isolation from biological media for protein corona analysis: The impact of incubation and recovery protocols on nanoparticle attributes|ChemRxiv|2023|2Evaluating the impact of experimental shear flow parameters on nanoparticle protein corona formation|ChemRxiv|2023|1